AI assistant
Sending…
Candel Therapeutics, Inc. — Director's Dealing 2021
Aug 3, 2021
33336_dirs_2021-08-02_c3b7b061-34d5-40c8-af3e-c62313cc1d18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Candel Therapeutics, Inc. (CADL)
CIK: 0001841387
Period of Report: 2021-07-29
Reporting Person: Nguyen Diem (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-29 | Common Stock | P | 10000 | $8.00 | Acquired | 10000 | Direct |
More from Candel Therapeutics, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Director's Dealing
2026
Feb 26
Regulatory Filings
2026
Feb 23
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Jan 28
Director's Dealing
2026
Jan 28
Director's Dealing
2026
Jan 28
Director's Dealing
2026
Jan 28